Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2010
08/11/2010CN101098867B Substituted sulfoxide compound and its preparing method and application
08/11/2010CN101049345B A preparation for treating disease of oral cavity and gorge, and preparation method
08/11/2010CN101036684B Isatis-Root extractive and the purifying method and the medicine combination
08/11/2010CN101011145B Edible Collybia albuminosa(Berk.) Petch stuffing
08/10/2010US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772239 Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists
08/10/2010US7772228 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010US7772198 cycstic fibrosis transmembrane conductance regulators (CFTR); for treatment of cystic fibrosis, asthma or diarrhea
08/10/2010US7772001 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
08/10/2010US7771982 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci
08/10/2010US7771748 Reducing smoking; side effect reduction
08/10/2010US7771747 Gastric acid secretion inhibiting composition
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2415957C Dry powder formulation comprising racecadotril
08/10/2010CA2413809C Synergistic antiplaque/antigingivitis oral composition
08/10/2010CA2391832C Oral dosage forms
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/05/2010WO2010087577A2 Use of thymus capitatus extract, satureja hortensis extract, or carvacrol for treating metabolic diseases
08/05/2010WO2010087517A1 Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism
08/05/2010WO2010087447A1 Finely pulverized pharmaceutical composition
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087358A1 Novel composition
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010087150A1 Gastric acid secretion inhibitor, and potassium channel inhibitor
08/05/2010WO2010086646A1 Scriptaid isosteres and their use in therapy
08/05/2010WO2010086280A1 Novel n-oxides of furanyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086278A1 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010085975A1 Pharmaceutical preparation comprising lipase of bacterial origin
08/05/2010WO2010063470A3 Methods for preventing or reducing colon carcinogenesis
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197778 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
08/05/2010US20100197724 6.5 -pyrrolopiperidine tachykinin receptor antagonists
08/05/2010US20100197721 PYRROLO [3, 4-h] ISOQUINOLINE COMPOUNDS AND METHODS FOR MODULATING GATED ION CHANNELS
08/05/2010US20100197714 Spiro-pyrano-pyrazole derivatives
08/05/2010US20100197712 Use of dopamine stabilizers
08/05/2010US20100197683 Fused ring compound and use thereof
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197657 2-aryl or heteroaryl indole derivatives
08/05/2010US20100197648 Treatment of irritable bowel syndrome and related bowel disease
08/05/2010US20100197642 Slow release misoprostol for obstetric and/or gynaecological applications
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
08/05/2010US20100197564 Diaryl morpholines as cb1 modulators
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100197015 Human liver progenitors
08/05/2010US20100196518 Method and Device for the Treatment of Water for Purposes Conducive to Good Health
08/05/2010US20100196494 Enhanced antimicrobial activity compositions of blends of plant essential oils
08/05/2010US20100196488 Pharmaceutical Formulation
08/05/2010US20100196479 METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
08/05/2010US20100196472 Modified release compositions of milnacipran
08/05/2010US20100196466 Drug delivery system
08/05/2010US20100196406 Agents for the treatment of inflammatory diseases and methods of using same
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196359 Human Monoclonal Antibody Human CD134 (Ox40) and Methods of Making and Using Same
08/05/2010US20100196340 Lactid acid bacteria as priobiotic strains and compositions containing same
08/05/2010US20100196269 Spirocyclic heterocyclic derivatives and methods of their use
08/05/2010DE102009006594A1 Pharmaceutical preparation, useful for the treatment of digestive disorders, cystic fibrosis and pancreatitis, comprises a liquid dosage form of enzymes
08/05/2010CA2751236A1 Finely pulverized pharmaceutical composition
08/05/2010CA2751041A1 Prophylactic agent or therapeutic agent for disease resulting from abnormal bone metabolism
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010CA2750086A1 Scriptaid isosteres and their use in therapy
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213736A2 Method for inhibiting the expression of a target gene and medicine for treating a tumour illness
08/04/2010EP2213675A1 Pyridooxazepine derivative and use thereof
08/04/2010EP2213305A1 Method for producing granulated matter
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010EP2212299A1 Piperazinyl-sulfonamide derivatives useful in the treatment of gpr38 receptor mediated diseases
08/04/2010EP2211875A1 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
08/04/2010EP2211854A1 Methods and compositions for the treatment of cancer using benzopyrone-type parp inhibitors
08/04/2010EP1670481B1 Use of ciclesonide for the treatment of inflammatory bowel diseases
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN1803147B The effect of a buffering agent on acidogenesis of plaque
08/04/2010CN1360502B Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders
08/04/2010CN101796039A Phenylacetic acid compound
08/04/2010CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody
08/04/2010CN101795686A Dentifrice compositions for treating xerostomia
08/04/2010CN101795685A hydroxyproline compositions and uses thereof
08/04/2010CN101792788A Preparation method of 5'-acylated cytidine and application in preparing medicaments for treating heart and liver diseases
08/04/2010CN101792783A Preparation method and application of banana natural resistant starch RS2
08/04/2010CN101792759A Immune co-enhancing molecule prepared by genetic engineering and immunopotentiation application thereof
08/04/2010CN101792708A Cinnamon-longan Hakka mother wine, preparation method thereof and application as mind-tranquilizing and digestion-aiding beverage
08/04/2010CN101792483A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus
08/04/2010CN101792441A Crystal forms of palonosetron hydrochloride and preparation method thereof
08/04/2010CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1
08/04/2010CN101792417A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
08/04/2010CN101792415A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/04/2010CN101792385A Sofalcone crystals VIII, preparation method thereof and use thereof
08/04/2010CN101791412A Acyclovir-chitosan-stearic acid grafting, synthetic method and application thereof
1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 1258